Potassium aspartate

Potassium aspartate
Names
IUPAC name
L-aspartic acid potassium salt
Other names
L-Aspartic acid, potassium salt (1:1);
Aspartic acid, monopotassium salt, L-;
L-Aspartic acid, monopotassium salt;
Monopotassium aspartate;
Potassium hydrogen aspartate;
Aspartic acid monopotassium salt;
Aspara K
Identifiers
3D model (JSmol)
ChemSpider
DrugBank
ECHA InfoCard 100.012.934 Edit this at Wikidata
EC Number
  • 214-226-4
KEGG
UNII
  • InChI=1S/C4H7NO4.K/c5-2(4(8)9)1-3(6)7;/h2H,1,5H2,(H,6,7)(H,8,9);/q;+1/p-1/t2-;/m0./s1
    Key: TXXVQZSTAVIHFD-DKWTVANSSA-M
  • C([C@@H](C(=O)[O-])[NH3+])C(=O)[O-].[K+]
Properties
C4H6KNO4
Molar mass 171.193 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Potassium aspartate is a potassium salt of L-aspartic acidKO2CCH(NH2)CH2CO2H·H2O.Potassium aspartate is also employed in cosmetics as a buffering agent.[citation needed]

The compound is used, as a chloride substitute in patch-clamp pipette solutions

Chemical properties

Potassium aspartate is a white powder that is water-soluble. Potassium aspartate hemihydrate (C4H6KNO4·½H2O) has a molar mass of 180.20 g/mol and contains approximately 21.7% potassium by mass, or about 217 mg of elemental potassium per gram. For example, the 166.3 mg of potassium aspartate hemihydrate in one Panangin tablet (corresponding to 158 mg of the anhydrous salt) supplies 36.2 mg of K+. potassium for example2++

A box with tablets of potassium aspartate and magnesium aspartate

Medical application

Potassium aspartate is not approved for use as a chemical in its own right (but may be approved as a component in a product covered by a group standard) in the United States or European Union or New Zealand or Australia, for treating any medical condition, but is studied as an alternative to potassium chloride to treat high blood pressure (hypertension): potassium chloride reduces blood pressure, with a more pronounced effect in patients with hypertension, averaging a reduction of 8.2 mm Hg systolic and 4.5 mm Hg diastolic; potassium aspartate may have a greater impact on lowering blood pressure at lower doses. Increasing intake of potassium-rich foods such as bananas, grapefruit, dried beans, peas, broccoli, spinach, pumpkins and squash is preferable, and potassium aspartate is studied as a potential adjunctive treatment for hypertension. Potassium aspartate is sometimes marketed in a mixture with magnesium aspartate.

Clinical evidence for the superiority of potassium aspartate is limited.

Chronic fatigue

Studies potassium 1 g 75%–91% 4–10 days with 9%–26%

See also